Meng‐Feng Tsai

2.4k total citations
57 papers, 1.9k citations indexed

About

Meng‐Feng Tsai is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Meng‐Feng Tsai has authored 57 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 16 papers in Molecular Biology. Recurrent topics in Meng‐Feng Tsai's work include Lung Cancer Treatments and Mutations (17 papers), Cancer Cells and Metastasis (6 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Meng‐Feng Tsai is often cited by papers focused on Lung Cancer Treatments and Mutations (17 papers), Cancer Cells and Metastasis (6 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Meng‐Feng Tsai collaborates with scholars based in Taiwan, United States and China. Meng‐Feng Tsai's co-authors include Pan‐Chyr Yang, Jin‐Yuan Shih, James Chih‐Hsin Yang, Shang‐Gin Wu, Chong‐Jen Yu, Yih‐Leong Chang, Jeremy J.W. Chen, Tzu‐Hua Chang, Pei‐Li Yao and Yinan Liu and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Meng‐Feng Tsai

55 papers receiving 1.9k citations

Peers

Countries citing papers authored by Meng‐Feng Tsai

Since Specialization

Citations

This map shows the geographic impact of Meng‐Feng Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng‐Feng Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng‐Feng Tsai more than expected).

Fields of papers citing papers by Meng‐Feng Tsai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng‐Feng Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng‐Feng Tsai. The network helps show where Meng‐Feng Tsai may publish in the future.

Co-authorship network of co-authors of Meng‐Feng Tsai

This figure shows the co-authorship network connecting the top 25 collaborators of Meng‐Feng Tsai. A scholar is included among the top collaborators of Meng‐Feng Tsai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng‐Feng Tsai. Meng‐Feng Tsai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	LncRNA SLCO4A1-AS1 suppresses lung cancer progression by sequestering the TOX4-NTSR1 signaling axis 2023 ·Journal of Biomedical Science ·Yi‐Ling Chen, Yinan Liu, Yen‐Ting Lin, Meng‐Feng Tsai, Shang‐Gin Wu, Tzu‐Hua Chang, Chia‐Lang Hsu, Huey‐Dong Wu, Jin‐Yuan Shih	14
2	miR-204 suppresses cancer stemness and enhances osimertinib sensitivity in non-small cell lung cancer by targeting CD44 2023 ·Molecular Therapy — Nucleic Acids ·Shang‐Gin Wu, Tzu‐Hua Chang, Meng‐Feng Tsai, Yinan Liu, (unknown), Chia‐Lang Hsu, (unknown), Jin‐Yuan Shih	12
3	Different treatment efficacies and T790M acquisition of EGFR‐TKIs on NSCLC patients with variable Del‐19 subtypes of EGFR 2023 ·International Journal of Cancer ·Shang‐Gin Wu, Chien‐Hung Gow, Yi‐Ling Chen, (unknown), Meng‐Feng Tsai, Jin‐Yuan Shih	4
4	MiR‐503 pleiotropically regulates epithelial‐mesenchymal transition and targets PTK7 to control lung cancer metastasis 2023 ·Cancer Medicine ·Tzu‐Hsiu Tsai, Chien‐Hung Gow, (unknown), Meng‐Feng Tsai, Tzu‐Hua Chang, Shang‐Gin Wu, Min‐Shu Hsieh, Kang‐Yi Su, Jin‐Yuan Shih	6
5	CD44s and CD44v8-10 isoforms confer acquired resistance to osimertinib by activating the ErbB3/STAT3 signaling pathway 2023 ·Life Sciences ·Yinan Liu, Meng‐Feng Tsai, Shang‐Gin Wu, Tzu‐Hua Chang, Jin‐Yuan Shih	6
6	miR-146b-5p Enhances the Sensitivity of NSCLC to EGFR Tyrosine Kinase Inhibitors by Regulating the IRAK1/NF-κB Pathway 2020 ·Molecular Therapy — Nucleic Acids ·Yinan Liu, Meng‐Feng Tsai, Shang‐Gin Wu, Tzu‐Hua Chang, Tzu‐Hsiu Tsai, Chien‐Hung Gow, Hsin‐Yi Wang, Jin‐Yuan Shih	38
7	Oncogenic Function of a KIF5B-MET Fusion Variant in Non-Small Cell Lung Cancer 2018 ·Neoplasia ·Chien‐Hung Gow, Yinan Liu, (unknown), Min‐Shu Hsieh, (unknown), (unknown), Tzu‐Hsiu Tsai, Pei‐Lung Chen, Meng‐Feng Tsai, Jin‐Yuan Shih	27
8	Investigating the Influence of Anti-Cancer Drugs on the Mechanics of Cells Using AFM 2015 ·BioNanoScience ·(unknown), Meng‐Feng Tsai	16
9	Clinical and the Prognostic Characteristics of Lung Adenocarcinoma Patients with ROS1 Fusion in Comparison with Other Driver Mutations in East Asian Populations 2014 ·Journal of Thoracic Oncology ·Yen‐Fu Chen, Min‐Shu Hsieh, Shang‐Gin Wu, Yih‐Leong Chang, Jin‐Yuan Shih, Yinan Liu, Meng‐Feng Tsai, Tzu‐Hsiu Tsai, Chong‐Jen Yu, James Chih‐Hsin Yang, Pan‐Chyr Yang	66
10	Tumour suppressor HLJ1: A potential diagnostic, preventive and therapeutic target in non-small cell lung cancer 2014 ·World Journal of Clinical Oncology ·Meng‐Feng Tsai	20
11	α-Synuclein and β-synuclein enhance secretion protein production in baculovirus expression vector system 2013 ·Applied Microbiology and Biotechnology ·(unknown), (unknown), Meng‐Feng Tsai, Tzong‐Yuan Wu	2
12	Survival of lung adenocarcinoma patients with malignant pleural effusion 2012 ·European Respiratory Journal ·Shang‐Gin Wu, Chong‐Jen Yu, Meng‐Feng Tsai, Wei‐Yu Liao, James Chih‐Hsin Yang, I‐Shiow Jan, Pan‐Chyr Yang, Jin‐Yuan Shih	79
13	ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors 2012 ·Cancer Letters ·Cheng-Po Huang, Meng‐Feng Tsai, Tzu‐Hua Chang, (unknown), Suyu Chen, (unknown), Ting‐Yu Lin, James Chih‐Hsin Yang, Pan‐Chyr Yang, Jin‐Yuan Shih, Shwu‐Bin Lin	129
14	Effusion Immunocytochemistry as an Alternative Approach for the Selection of First-Line Targeted Therapy in Advanced Lung Adenocarcinoma 2012 ·Journal of Thoracic Oncology ·Tzu‐Hsiu Tsai, Shang‐Gin Wu, Yih‐Leong Chang, Chen‐Tu Wu, Meng‐Feng Tsai, (unknown), James Chih‐Hsin Yang, Chong‐Jen Yu, Pan‐Chyr Yang, Jin‐Yuan Shih	31
15	EML4-ALK Translocation Predicts Better Outcome in Lung Adenocarcinoma Patients with Wild-Type EGFR 2011 ·Journal of Thoracic Oncology ·Shang‐Gin Wu, Yao-Wen Kuo, Yih‐Leong Chang, Jin‐Yuan Shih, Yahui Chen, Meng‐Feng Tsai, Chong‐Jen Yu, James Chih‐Hsin Yang, Pan‐Chyr Yang	80
16	Including Total EGFR Staining in Scoring Improves EGFR Mutations Detection by Mutation-Specific Antibodies and EGFR TKIs Response Prediction 2011 ·PLoS ONE ·Shang‐Gin Wu, Yih‐Leong Chang, Jou‐Wei Lin, Chen‐Tu Wu, Hsuan‐Yu Chen, Meng‐Feng Tsai, Yung-Chie Lee, Chong‐Jen Yu, Jin‐Yuan Shih	43
17	Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma 2009 ·Medical Oncology ·Chun‐Ta Huang, Ruoh‐Fang Yen, Mei‐Fang Cheng, Y. L. Hsu, (unknown), Yi‐Ju Tsai, Meng‐Feng Tsai, Jin‐Yuan Shih, James Chih‐Hsin Yang, Pan‐Chyr Yang	57
18	Curcumin Inhibits Lung Cancer Cell Invasion and Metastasis through the Tumor Suppressor HLJ1 2008 ·Cancer Research ·Huei‐Wen Chen, Jen‐Yi Lee, Jiying Huang, Chi‐Chuan Wang, Wan-Jiun Chen, Sheng‐Fang Su, Chia-Wen Huang, Chao‐Chi Ho, Jeremy J.W. Chen, Meng‐Feng Tsai, Sung‐Liang Yu, Pan‐Chyr Yang	189
19	Global expression profiling of theophylline response genes in macrophages: evidence of airway anti-inflammatory regulation 2005 ·Respiratory Research ·Pei‐Li Yao, Meng‐Feng Tsai, Yi‐Chen Lin, Chien-Hsun Wang, Wei‐Yu Liao, Jeremy J.W. Chen, Pan‐Chyr Yang	22
20	Cloning, Characterization, and Phylogenetic Analysis of a Shrimp White Spot Syndrome Virus Gene That Encodes a Protein Kinase 2001 ·Virology ·(unknown), Hon‐Tsen Yu, (unknown), (unknown), (unknown), Kate Ching‐Ju Lin, Chiu-Jung Huang, Meng‐Feng Tsai, Chang‐Jen Huang, Chung‐Hsiung Wang, Jung‐Yaw Lin, Chu‐Fang Lo, Guang‐Hsiung Kou	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact